Abiopharma

🔍 WILLIS CHARLES F IV (Executive)

Company: WILLIS LEASE FINANCE CORP (WLFC)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Sold 16,032 shares of Common Stock at $57.4485 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 2,627,811.00 | transaction_form_type: 4 | Footnotes: F2, F3, F1
• Sold 13,590 shares of Common Stock at $58.3824 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 2,614,221.00 | transaction_form_type: 4 | Footnotes: F2, F4
• Sold 1,778 shares of Common Stock at $58.8532 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 2,612,443.00 | transaction_form_type: 4 | Footnotes: F2, F5
• Sold 6,485 shares of Common Stock at $56.61 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 2,605,958.00 | transaction_form_type: 4 | Footnotes: F2, F6
• Sold 12,480 shares of Common Stock at $57.4576 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 2,593,478.00 | transaction_form_type: 4 | Footnotes: F2, F7
• Sold 8,535 shares of Common Stock at $58.192 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 2,584,943.00 | transaction_form_type: 4 | Footnotes: F2, F8
• Sold 11,357 shares of Common Stock at $55.1137 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 2,573,586.00 | transaction_form_type: 4 | Footnotes: F2, F9
• Sold 3,133 shares of Common Stock at $56.4812 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 2,570,453.00 | transaction_form_type: 4 | Footnotes: F2, F10
• Sold 4,810 shares of Common Stock at $57.2701 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 2,565,643.00 | transaction_form_type: 4 | Footnotes: F2, F11
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-17 | Code: H | nature_of_ownership: Spouse | shares_owned_after: 40,680.00 | Footnotes: F1, F12
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-17 | Code: H | nature_of_ownership: CFW Partners | shares_owned_after: 6,402,445.00 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-17 | Code: H | nature_of_ownership: Granddaughter | shares_owned_after: 1,752.00 | Footnotes: F1, F13

Footnotes:

• F1: These numbers have been adjusted to reflect the 3-for-1 forward stock split, which became effective on July 21, 2026 (the "Stock Split").
• F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2026.
• F3: This transaction was executed in multiple trades at prices ranging from $56.80 to $57.75, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) of this Form 4.
• F4: This transaction was executed in multiple trades at prices ranging from $57.81 to $58.80, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) of this Form 4.
• F5: This transaction was executed in multiple trades at prices ranging from $58.81 to $58.90, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) of this Form 4.
• F6: This transaction was executed in multiple trades at prices ranging from $56.01 to $57.00, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) of this Form 4.
• F7: This transaction was executed in multiple trades at prices ranging from $57.015 to $57.99, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (7) of this Form 4.
• F8: This transaction was executed in multiple trades at prices ranging from $58.04 to $58.48, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (8) of this Form 4.
• F9: This transaction was executed in multiple trades at prices ranging from $54.87 to $55.37, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (9) of this Form 4.
• F10: This transaction was executed in multiple trades at prices ranging from $56.00 to $56.99, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (10) of this Form 4.
• F11: This transaction was executed in multiple trades at prices ranging from $57.03 to $57.95, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in footnote (11) of this Form 4.
• F12: Charlotte Montressor Willis.
• F13: Wilder Grace Willis 2016 Trust.